Ishir Bhan

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 7

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

EJHaem

International journal of endocrinology

CNS drugs

Biogen Idec Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Biogen Idec Inc Oct 31 2016

United States

Associate Medical Director :: Safety and Benefit Risk

Massachusetts General Hospital Jul 01 2008 - Oct 31 2016

United States

Assistant in Medicine :: Division of Nephrology, Department of Medicine

Publications

Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Anna Gaya, Talha Munir, Alvaro Urbano-Ispizua, Morag Griffin, Jorg Taubel, Jim Bush, Ishir Bhan, Anna Borodovsky, Yue Wang, Prajakta Badri, Pushkal Garg
Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria. EJHaem 4 (3) (2023)
Basil T Darras, Michelle A Farrar, Eugenio Mercuri, Richard S Finkel, Richard Foster, Steven G Hughes, Ishir Bhan, Wildon Farwell, Sarah Gheuens
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials. CNS drugs 33 (9) (2020)
Ishir Bhan
Vitamin d binding protein and bone health. International journal of endocrinology 2014 (2014)

Ishir Bhan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ishir Bhan